Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.34)
# 1,012
Out of 4,913 analysts
141
Total ratings
49.64%
Success rate
2.11%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CNC Centene | Maintains: Outperform | $85 → $51 | $27.73 | +83.95% | 18 | Jul 15, 2025 | |
UNH UnitedHealth Group | Maintains: Outperform | $600 → $400 | $282.80 | +41.44% | 16 | May 14, 2025 | |
HUM Humana | Maintains: Outperform | $300 → $310 | $236.25 | +31.22% | 13 | May 1, 2025 | |
CI The Cigna Group | Maintains: Outperform | $400 → $375 | $294.97 | +27.13% | 11 | Jan 31, 2025 | |
TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $8.24 | +45.72% | 11 | Jan 24, 2025 | |
PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $23.32 | +58.70% | 6 | Nov 8, 2024 | |
HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $335.66 | +19.17% | 11 | Oct 28, 2024 | |
ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $150.11 | +11.92% | 8 | Oct 25, 2024 | |
ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $109.07 | +32.95% | 10 | Sep 23, 2024 | |
PACS PACS Group | Maintains: Outperform | $32 → $40 | $11.64 | +243.64% | 3 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.66 | +88.32% | 10 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $6.73 | - | 2 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $468.36 | +38.78% | 12 | Feb 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $97.83 | +48.22% | 10 | Oct 28, 2022 |
Centene
Jul 15, 2025
Maintains: Outperform
Price Target: $85 → $51
Current: $27.73
Upside: +83.95%
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600 → $400
Current: $282.80
Upside: +41.44%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $236.25
Upside: +31.22%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $294.97
Upside: +27.13%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $8.24
Upside: +45.72%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $23.32
Upside: +58.70%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $335.66
Upside: +19.17%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $150.11
Upside: +11.92%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $109.07
Upside: +32.95%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $11.64
Upside: +243.64%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.66
Upside: +88.32%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $6.73
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $468.36
Upside: +38.78%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $97.83
Upside: +48.22%